12:00 AM
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bosutinib regulatory update

EMA accepted for review an MAA from Pfizer for bosutinib to treat newly diagnosed Philadelphia chromosome-positive (Ph+)...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >